AC Immune
Presence
AC Immune is a company listed under the stock ticker ACIU (CH).
Executives
View the org chart displaying its 18 main executives
Most searched biographies at AC Immune
- Andrea Pfeifer, Chief Executive Officer and Director
- Monica Shaw, Director
- Douglas Williams, Chairman of the Board
Popular executive movements at AC Immune
- Christopher Roberts, who was Interim Chief Financial Officer Vice President, Finance, is promoted to Chief Financial Officer (posted on December 3 2023).
- Madiha Derouazi has joined the company as Chief Scientific Officer (posted on December 3 2023).
- Johannes Streffer, Chief Medical Officer, will leave the company on Sep. 1, 2023 (posted on July 27 2023).
Click here to view some more movements at AC Immune
Create your alert
to follow the executive moves at AC Immune.
Biotechnology
AC Immune has 2,281 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Endeavor BioMedicines has just announced a $132 Million fundraising (posted on April 25 2024).
- Metsera has just announced a $290 Million fundraising (posted on April 23 2024).
- Histogen has filed for bankruptcy protection (posted on April 19 2024).
Popular contacts in Biotechnology
News
Press releases by AC Immune
- Detailed Data From the Phase II Crenezumab Alzheimer’s Prevention Initiative Study in Autosomal Dominant Alzheimer’s Disease Presented at AAIC | AC Immune SA
- AC Immune Reports Second Quarter 2022 Financial Results and Provides Corporate Update | AC Immune SA
- AC Immune Announces Upcoming Presentations at the Alzheimer’s Association International Conference | AC Immune SA
- AC Immune Holds Annual General Meeting of Shareholders | AC Immune SA
- AC Immune Provides Update on Alzheimer’s Prevention Initiative Study Evaluating Crenezumab in Autosomal Dominant Alzheimer’s Disease | AC Immune SA
- AC Immune to Present at the 2022 Jefferies Healthcare Conference | AC Immune SA
- AC Immune CEO Andrea Pfeifer Receives Aenne Burda Award | AC Immune SA
- AC Immune’s Anti-Abeta Vaccine Results from Phase 1b Study in Down Syndrome Published in JAMA Neurology | AC Immune SA
- AC Immune Reports First Quarter 2022 Financial Results and Provides Corporate Update | AC Immune SA
- AC Immune to Present at the B. Riley Annual Neuro & Ophthalmology Virtual Investor Conference | AC Immune SA
- View more press releases Close
Social media about AC Immune
- AC Immune on Wikipedia, Google News & Yahoo Finance
- AC Immune on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Andrea Pfeifer 
